Cas no 79134-68-2 (Pyridine, 3-cyclopentyl-)

Pyridine, 3-cyclopentyl-, is a substituted pyridine derivative featuring a cyclopentyl group at the 3-position. This structural modification enhances its steric and electronic properties, making it a valuable intermediate in organic synthesis and pharmaceutical applications. The cyclopentyl moiety contributes to increased lipophilicity, potentially improving bioavailability in drug development. Its rigid structure also offers stability in catalytic and coordination chemistry. The compound is typically used in the preparation of specialized ligands, agrochemicals, and bioactive molecules. High purity grades ensure consistent performance in research and industrial processes. Proper handling is advised due to its potential reactivity under certain conditions.
Pyridine, 3-cyclopentyl- structure
Pyridine, 3-cyclopentyl- structure
Product Name:Pyridine, 3-cyclopentyl-
CAS No:79134-68-2
MF:C10H13N
MW:147.216922521591
CID:533307
PubChem ID:21963860
Update Time:2025-10-29

Pyridine, 3-cyclopentyl- Chemical and Physical Properties

Names and Identifiers

    • Pyridine, 3-cyclopentyl-
    • 3-cyclopentylpyridine
    • SCHEMBL6095783
    • FT-0764700
    • EN300-202009
    • WSAFCRLBAFJPTN-UHFFFAOYSA-N
    • DTXSID80620881
    • 79134-68-2
    • Inchi: 1S/C10H13N/c1-2-5-9(4-1)10-6-3-7-11-8-10/h3,6-9H,1-2,4-5H2
    • InChI Key: WSAFCRLBAFJPTN-UHFFFAOYSA-N
    • SMILES: N1C=CC=C(C=1)C1CCCC1

Computed Properties

  • Exact Mass: 147.104799419g/mol
  • Monoisotopic Mass: 147.104799419g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 1
  • Complexity: 116
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.8
  • Topological Polar Surface Area: 12.9?2

Pyridine, 3-cyclopentyl- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Enamine
EN300-202009-0.05g
3-cyclopentylpyridine
79134-68-2 90%
0.05g
$101.0 2023-06-04
Enamine
EN300-202009-0.1g
3-cyclopentylpyridine
79134-68-2 90%
0.1g
$152.0 2023-06-04
Enamine
EN300-202009-0.25g
3-cyclopentylpyridine
79134-68-2 90%
0.25g
$216.0 2023-06-04
Enamine
EN300-202009-0.5g
3-cyclopentylpyridine
79134-68-2 90%
0.5g
$407.0 2023-06-04
Enamine
EN300-202009-1.0g
3-cyclopentylpyridine
79134-68-2 90%
1g
$528.0 2023-06-04
Enamine
EN300-202009-2.5g
3-cyclopentylpyridine
79134-68-2 90%
2.5g
$1034.0 2023-06-04
Enamine
EN300-202009-5.0g
3-cyclopentylpyridine
79134-68-2 90%
5g
$1530.0 2023-06-04
Enamine
EN300-202009-10.0g
3-cyclopentylpyridine
79134-68-2 90%
10g
$2269.0 2023-06-04
1PlusChem
1P0053X8-50mg
Pyridine, 3-cyclopentyl-
79134-68-2 90%
50mg
$182.00 2024-04-21
1PlusChem
1P0053X8-100mg
Pyridine, 3-cyclopentyl-
79134-68-2 90%
100mg
$243.00 2024-04-21

Pyridine, 3-cyclopentyl- Related Literature

Additional information on Pyridine, 3-cyclopentyl-

Recent Advances in the Study of Pyridine, 3-cyclopentyl- (CAS: 79134-68-2): A Comprehensive Research Brief

Pyridine, 3-cyclopentyl- (CAS: 79134-68-2) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound, characterized by its pyridine core substituted with a cyclopentyl group at the 3-position, has shown promise in various applications, including drug discovery and material science. Recent studies have explored its potential as a building block for novel therapeutic agents, particularly in the development of kinase inhibitors and other small-molecule modulators of biological targets.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of Pyridine, 3-cyclopentyl- in the synthesis of selective kinase inhibitors. The study highlighted the compound's ability to enhance binding affinity and selectivity due to its unique steric and electronic properties. The researchers employed a combination of computational modeling and in vitro assays to demonstrate that derivatives of Pyridine, 3-cyclopentyl- could effectively target specific kinase isoforms, offering a potential pathway for the treatment of cancers and inflammatory diseases.

Another significant development was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where Pyridine, 3-cyclopentyl- was utilized as a key intermediate in the synthesis of novel antiviral agents. The study focused on its incorporation into nucleoside analogs, which exhibited potent activity against RNA viruses. The researchers emphasized the compound's versatility and its potential to serve as a scaffold for the development of broad-spectrum antiviral therapies.

Beyond its pharmaceutical applications, Pyridine, 3-cyclopentyl- has also been explored in material science. A recent study in ACS Applied Materials & Interfaces demonstrated its utility in the design of organic semiconductors. The compound's rigid yet flexible structure was found to enhance charge transport properties, making it a candidate for use in next-generation electronic devices.

Despite these advancements, challenges remain in the large-scale synthesis and optimization of Pyridine, 3-cyclopentyl- derivatives. Issues such as yield optimization, regioselectivity, and scalability need to be addressed to fully realize its potential. Future research directions may include the development of greener synthetic routes and the exploration of its applications in other therapeutic areas, such as neurodegenerative diseases and metabolic disorders.

In conclusion, Pyridine, 3-cyclopentyl- (CAS: 79134-68-2) represents a versatile and promising compound in the fields of chemical biology and pharmaceutical research. Its unique structural features and diverse applications underscore its importance as a subject of ongoing investigation. Continued research and innovation will be essential to unlock its full potential and translate these findings into practical solutions for human health and technology.

Recommended suppliers
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd